While we cannot directly compare the results of one trial to another, berobenatides phase 2b trial results suggest that its weight loss efficacy may be similar to semaglutide for individuals with obesity, both with and without type 2 diabetes, Ho explains
GLP-1 weight loss support at Ideal Protocol combines provider-supported semaglutide and tirzepatide options when clinically appropriate with structured nutrition, weekly coaching, daily text education, body composition tracking, mindset support, and real accountability so you are not trying to figure it out alone
Retatrutide as a single agent outperforms cagrilintide as a single agent by a significant margin
This effect is achieved through the activation of signaling pathways such as the ERK1/2, PI3K/AKT, and cAMP/PKA/-cat-Ser675 pathways, which are mediated by GLP-1RAs
& Flohe, L